Zupancic D, Korac-Prlic J, Kreft M, Frankovic L, Vilovic K, Jeruc J
Cancers (Basel). 2020; 12(7).
PMID: 32605249
PMC: 7407197.
DOI: 10.3390/cancers12071712.
Dahm H, Lehnen-Holtum V, Rubben H
Urologe A. 2016; 55(10):1329-1334.
PMID: 27246476
DOI: 10.1007/s00120-016-0078-5.
Dahm H, von der Haar C, Rubben H
J Cancer Res Clin Oncol. 2016; 142(6):1253-60.
PMID: 27033373
PMC: 4865537.
DOI: 10.1007/s00432-016-2153-0.
Hudoklin S, Zupancic D, Makovec D, Kreft M, Romih R
Int J Nanomedicine. 2013; 8:3945-53.
PMID: 24143099
PMC: 3798153.
DOI: 10.2147/IJN.S44363.
Zupancic D, Kreft M, Romih R
Protoplasma. 2013; 251(1):49-59.
PMID: 23828036
DOI: 10.1007/s00709-013-0524-9.
Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Zupancic D, Ovcak Z, Vidmar G, Romih R
Virchows Arch. 2011; 458(5):603-13.
PMID: 21301865
DOI: 10.1007/s00428-011-1045-6.
Morphological changes of microvilli on different surfaces of epithelial cells in the rat bladder treated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
Zhang X, Takenaka I
Urol Res. 1995; 23(6):371-6.
PMID: 8788274
DOI: 10.1007/BF00698736.
Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon.
Hicks R, James C, WEBBE G
Br J Cancer. 1980; 42(5):730-55.
PMID: 7459210
PMC: 2010559.
DOI: 10.1038/bjc.1980.308.
Scanning electron microscopic examination of reversible hyperplasia of the rat urinary bladder.
Fukushima S, Cohen S, Arai M, Jacobs J, FRIEDELL G
Am J Pathol. 1981; 102(3):373-80.
PMID: 7212020
PMC: 1903725.
Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
Ito N, Fukushima S, Shirai T, Nakanishi K
Environ Health Perspect. 1983; 50:61-9.
PMID: 6873032
PMC: 1569218.
DOI: 10.1289/ehp.835061.
Comparative light and scanning electron microscopic observations of nasal cavity carcinogenesis in rats treated with 1,4-dinitrosopiperazine.
Tsuda H, Takano T, Shirai T, Suzuki M, Baba S, Ito N
J Cancer Res Clin Oncol. 1984; 108(2):186-91.
PMID: 6470025
DOI: 10.1007/BF00402465.
Scanning electron microscopy of changes in the urinary bladder in dogs treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
Hirao Y, Sasaki K, Sanma S, Ozono S, Babaya K, Okajima E
Urol Res. 1987; 15(1):25-9.
PMID: 3824711
DOI: 10.1007/BF00256331.
Nonspecific esterase reaction in hyperplastic urinary bladder epithelium induced by administration of N-butyl-N-(4-hydroxybutyl)nitrosamine, freezing and formalin instillation in rats.
AKAGI A, Otsuka H
Br J Exp Pathol. 1988; 69(3):367-77.
PMID: 3390388
PMC: 2013095.
Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J, Fukushima S, Imaida K, Ito N, Nagase S
Jpn J Cancer Res. 1988; 79(4):453-9.
PMID: 3133335
PMC: 5917500.
DOI: 10.1111/j.1349-7006.1988.tb01613.x.
Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression.
Herman C, Vegt P, Debruyne F, Vooijs G, Ramaekers F
Am J Pathol. 1985; 120(3):419-26.
PMID: 2412446
PMC: 1887986.
Reversible papillary hyperplasia of the rat urinary bladder.
Shirai T, Cohen S, Fukushima S, Hananouchi M, Ito N
Am J Pathol. 1978; 91(1):33-48.
PMID: 645820
PMC: 2018165.
Induction of transitional cell carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Histological and ultrastructural findings.
Adolphs H, Thiele J, Kiel H, Steffens L
Urol Res. 1978; 6(1):19-27.
PMID: 644727
DOI: 10.1007/BF00257078.
Transplantable acinar cell carcinoma of the rat pancreas.
Rao M, Reddy J
Am J Pathol. 1979; 94(2):333-48.
PMID: 426031
PMC: 2042242.
